This is a diffuse motor-sensory polyneuropathy that is predominantly axonal in nature. The neuropathy is present regardless of the etiology of the cirrhosis. The incidence and severity of this ...

HyQvia (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous infusion) is a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP ...

Chronic systemic inflammation occurs when the immune system is constantly at work. This can trigger an overreaction that causes the body to attack itself. Inflammation can be a sign of some very ...

She works on in-vitro and invivo peripheral neuropathy models of different chemotherapy drugs ... co- or pre-administered to cancer patients with chemotherapy agents before axonal degeneration start.

Key pathological findings included axonal damage, decreased nerve fiber density, and demyelination. A case of copper deficiency peripheral neuropathy (CDPN) associated with Wilson disease (WD) was ...

Children in the United States are increasingly suffering from persistent or severe health conditions, many of which are preventable and could follow them into adulthood, according to new research. The ...

Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profile of VYVGART and VYVGART Hytrulo gMG patients on VYVGART achieve rapid, substantial, and sustained efficacy ...

Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.

Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug t ...

We confirm that GCaMP6s activity within axonal projections of both basal forebrain cholinergic and locus coeruleus noradrenergic neurons track arousal, indexed as pupil diameter, and changes in ...

Anti-contactin-1 (CNTN1) IgG4 antibody-associated nodopathies is an autoimmune antibody-mediated peripheral neuropathy with a unique clinical ... in both lower extremities, axonal damage, prolonged ...